Lviv clinical bulletin 2021, 1(33)-2(34): 19-25

https://doi.org/10.25040/lkv2021.01-02.019

Disturbances of Cardiovascular Activity and Endothelial Function in Pregnant Women with Undifferentiated Connective Tissue Dysplasia and their Correction by Carnitine-arginine Complex Inclusion in the Protocol Treatment Program

Posted onAuthorAdminЗалишити коментар / Leave a comment

V. Dobrianska 

I. Horbachevsky Ternopil National Medical University

Context. Undifferentiated connective tissue dysplasia (UCTD) has negative impact on myocardial contractility and endothelial microvascular dysfunction and their frequent combination with cardiac arrhythmias suggests an unfavorable course of pregnancy and childbirth due to the formation of uteroplacental dysfunction.

Objective. To reduce the incidence of obstetric complications associated with cardiovascular disorders in women with UCTD by including carnitine-arginine complex in the treatment program.

Materials and methods. 58 pregnant women with diagnosed signs of UCTD, including mitral valve prolaps (MVP) with and without frequent extrasystoles, and 14 pregnant women of control group were examined. Metabolic support with of 4.2 g of L-arginine and 2.0 g of L-carnitine in the form of a solution for intravenous infusion once a day for 5 days were used for prenatal care of pregnant women with UCTD and prevention of obstetric complications in the experimental group.

Results. There are violations of morpho-functional parameters of the heart with the development of moderate systolic-diastolic myocardial dysfunction and endothelial microvascular dysfunction in the initial state of pregnant women with MVP and extrasystolic arrhythmia against the background of UCTD. They were significantly more often diagnosed with miscarriage, late preeclampsia, placental dysfunction, birth defects, birth trauma, postpartum hemorrhage, etc. Echostructural abnormalities of the heart acted as predictors of arrhythmias, the presence of which was associated with more pronounced disorders of intracardiac hemodynamics.

The results of a comprehensive study of the clinical and functional status of pregnant women with phenotypic signs of UCTD, MVP and extrasystolic arrhythmia suggest that in most cases they occur with moderate heart remodeling and significant endothelial dysfunction of the microvascular circulation, that was accompanied by significant deterioration of the obstetric situation. The use of standard medication by pregnant women did not significantly restore the incidence of arrhythmias, inotropic capacity of the myocardium and endothelial function of microvessels. Supraventricular and ventricular arrhythmias remained resistant to standard treatment, which justified the use of additional antiarrhythmic drugs. 

At the same time, there was a significant reduction in the incidence of arrhythmias in the group of patients with MVP and frequent ventricular or mixed extrasystoles – by 90.6 and 77.8 % respectively under the influence of complex drug treatment with the inclusion of L-arginine and L-carnitine. In the group of pregnant women with supraventricular arrhythmias, the antiarrhythmic effect was observed in only 37.5 % of patients, which justified the additional use of nebivolol hydrochloride at a dose of 2.5 mg/day. At the same time, such a comprehensive treatment in pregnant women with MVP and arrhythmia on the background of UCTD contributed to the restoration of the studied indicators of endothelial function of microvessels.

Conclusions. In pregnant women with MVP and extrasystolic arrhythmia against the background of UCTD in the initial state there are violations of morpho-functional parameters of the heart with the development of moderate systolic-diastolic myocardial dysfunction and endothelial microvascular dysfunction, which are triggers of complicated pregnancy and childbirth. The inclusion of L-arginine and L-carnitine led to a significant improvement in the parameters of central cardiohemodynamics and restoration of endothelial function of microvessels and accompanied by a significant reduction of the incidence of extrasystolic arrhythmia and pregnancy complications.

References

  1. Gazazyan, M.G. Features of the course of pregnancy and childbirth in patients with connective tissue dysplasia. Obstetrics and Gynecology. 2017;121:7 (Russian)
  2. Geryak SM, Dobryanska VYU, Dobryansky TO, Korda IV, Shved MI, Petrenko NV. Electrolyte disorders as a predictor of obstetric and perinatal complications in pregnant women with mitral valve collapse. Coll. Sci. Works of Obstetricians and Gynecologists of Ukraine. 2019:11-19 (Ukrainian) https://doi.org/10.35278/2664-0767.1(43).2019.177813
  3. Dobrokhotova YuE, Borovkova EI. Pregravid preparation and management of pregnancy in patients with connective tissue dysplasia. Gynecology. 2017;19(5):44-49 (Russian) https://doi.org/10.26442/2079-5696_19.5.44-49
  4. Dobryanska VYu, Heraiak SM, Shved MI. Predictors of extrasistic arrythmia and its treatment in pregnant military valve prolapses. Achievements of Clinical and Experimental Medicine. 2018;2:48-52 (Ukrainian)
  5. Zaremba EH, Karplyak VM, Rak NO, Zaremba-Fedchyshyn OV, Zaremba OV. Optimal method of treatment of arterial hypertension combined with dysplasia of connective tissue. Achievements of Clinical and Experimental Medicine. 2018;3:61-68 (Ukrainian)
  6. Il’ina IYu, Chikisheva AA. Features of the course of pregnancy in patients with connective tissue dysplasia. Mother and Child. 2020;3:182-188 (Russian) https://doi.org/10.32364/2618-8430-2020-3-3-182-188
  7. Kazachkova EA. Dysplasia of the connective tissue of the heart and pregnancy. Obstetrics and gynecology. 2017;1:127-32 (Russian)
  8. Kononenko IS. Genes polymorphisms of transforming growth factor b1 and matrix metalloproteinase 9 as molecular and genetic predictors of isthmic-cervical insufficiency development in female patients with undifferentiated connective tissue dysplasia. Vestnik VGMU. 2020;19(3):50-58 (Russian) https://doi.org/10.22263/2312-4156.2020.3.50
  9. Pavlenko M. Isthmic-cervical insufficiency. 2018 (Ukrainian)
  10. WHO recommendations for antenatal care for a positive pregnancy experience. Geneva; 2017 (Russian)
  11. Saryeva OP, Peretyatko LP, Vakhromeev AP, Pareishvili VV. Pathomorphology of the extraplacental membranes with their premature rupture and undifferentiated connective tissue dysplasia in women. Archive of Pathology. 2019;81(4):26-32 (Russian) https://doi.org/10.17116/patol20198103126
  12. Siromakha SO, Davydova YuV, Volkova NI, Lazoryshynets VV. Marfan syndrome and pregnancy. Actual Problems of Pediatrics, Obstetrics and Gynecology. 2020;1:94-101 (Ukrainian) https://doi.org/10.11603/24116-4944.2020.1.11492
  13. Smirnova TL, Gerasimova LI, Sidorov AYe, Chernyshov VV, Gubanova YeA. Features of the course of pregnancy and childbirth in women with the syndrome of undifferentiated connective tissue dysplasia. Practical Medicine. 2018;16(6):39-44 (Russian) https://doi.org/10.32000/2072-1757-2018-16-6-39-44
  14. Terekhovskaya YuV, Smirnova EA. Heart rhythm disord ers in pregnancy. ″Science of the young – Eruditio Juvenium″. 2017:462-480 (Russian) https://doi.org/10.23888/HMJ20173462-480
  15. Tetelyutina FK, Lagutko NN, Sushentsova TV, Badrieva YuN, Akhmedyanova RD. Indicators of biopolymers of conjunctive tissue dispersion in assessment of placentary insufficiency. Medical Newsletter of Vyatka. 2018;2(58):27-31 (Russian) https://doi.org/10.17116/rosakush20191902127
  16. Filipenko PS, Malookaya YuS. The role of connective tissue dysplasia in the formation of mitral valve prolapse. Clinical Medicine. 2006;84(12):13-19 (Russian)
  17. Chaika VK, Zheleznaya AA, Luneva NN. Management of complicated pregnancy in a pregnant woman with undifferentiated connective tissue dysplasia (clinical case). Medical and Social Problems of the Family. 2019;24(1):104-111 (Russian)
  18. Yashchuk AG, Maslennikov AV, Shiryaev AA. Functioning of the hemostatic system in pregnant women with undifferentiated connective tissue dysplasia. Practical Medicine. 2016;1(93):37-40 (Russian)
  19. Artal R, Greenspoon JS, Rutherford S. Transient ischemic attack: a complication of mitral valve prolapse in pregnancy. Obstet Gynecol. 1988;71(6 Pt 2):1028-1030.(17)
  20. Chia YT, Yeoh SC, Lim MC, Viegas OA, Ratnam SS. Pregnancy outcome and mitral valve prolapse. Asia Oceania J Obstet Gynaecol. 2016;20(4):383-388. https://doi.org/10.1111/j.1447-0756.1994.tb00485.x
  21. Faiz SA, Al-Meshari AA, Sporrong BG. Pregnancy and valvular heart disease. Saudi Med J. 2003;24(10):1098-1101.
  22. Garcia-Gonzаlez M, Rodríguez-Lozano B, Bustabad S, Ferraz-Amaro I. Undifferentiated connective tissue disease: predictors of evolution into definitedisease. Clin Exp Rheumatol. 2017;35(5):739-745.
  23. Jana N, Vasishta K, Khunnu B. Pregnancy in association with mitral valve prolapse. Asia Oceania J Obstet Gynaecol. 2017;19(1):61-65. https://doi.org/10.1111/j.1447-0756.1993.tb00348.x
  24. Jeresaty RM. Mitral valve prolapse. An update. JAMA. 1985;254(6):793-795. https://doi.org/10.1001/jama.1985.03360060095033
  25. Kucharczyk-Petryka E, Mamcarz A, Braksator W, Sawicki W, Dłuzniewski M. Mitral valve prolapse at pregnancy: is it a real clinical problem? Pol Arch Med Wewn. 2005;114(5):1084-1088.
  26. Lichodziejewska B, Klos J, Rezler J. Clinical symptoms of mitral valve prolapse are related to hypomagnesaemia and attenuated by magnesium supplementation. Am J Cardiol. 2017;79(6):768-772. https://doi.org/10.1016/S0002-9149(96)00865-X
  27. Nanna M, Stergiopoulos K. Pregnancy complicated by valvular heart disease: an update. J Am Heart Assoc. 2017;3(3):76-80. https://doi.org/10.1161/JAHA.113.000712
  28. Ohata Y, Ozono K, Michigami T. Current concepts in perinatal mineral metabolism. Clin Pediatr Endocrinol. 2016;25(1):9-17. https://doi.org/10.1297/cpe.25.9
  29. Shankar H, Kumar N, Sandhir R, Singh MP, Mittal S, Adhikari et al. Association of dietary intake below recommendations and micronutrient deficiencies during pregnancy and low birthweight. J Perinat Med. 2019;47(7):724-731. https://doi.org/10.1515/jpm-2019-0053
  30. Zoloto EV. Connective tissue dysplasia – a problem in modern medicine. University Clinic. 2018;4(29):109-116.